A Brain Hemorrhage Market, also known as a brain bleed or an intracranial hemorrhage, is a life-threatening medical illness in which a blood artery ruptures inside or over the surface of the brain, causing bleeding. Head trauma, aneurysm (swelling of artery owing to the weakness of artery wall), hypertension, congenital blood vessel anomalies, brain tumor, drug addiction, bleeding disorders such as hemophilia and sickle cell anemia, and others are some of the causes of a brain hemorrhage. Symptoms of a brain hemorrhage include abrupt severe headaches, nausea, tingling or numbness, tiredness, lack of coordination, seizures without prior medical history, changes in vision, loss of consciousness, difficulty speaking, weakness in a leg, loss of balance, and more. Intracerebral hemorrhage, subarachnoid hemorrhage, and subdural hemorrhage are the three forms of brain hemorrhage based on the location of bleeding.
The bleeding happens inside the brain in intracerebral hemorrhage. Subarachnoid hemorrhage occurs when blood flows between the brain and the membranes that surround it, whereas subdural Brain Hemorrhage Market occurs when blood flows between the inner layer of the dura (the membrane that surrounds the brain) and the brain. When an epidural hemorrhage occurs, blood clots between the skull and the brain.
Over the projected period, the worldwide brain hemorrhage market is expected to rise due to an increase in the occurrence of risk factors related to brain hemorrhages such as head injury, high blood pressure, brain tumor, aneurysm, and others.
According to data released by the National Center for Biotechnology Information in August 2021, the global prevalence of cerebral aneurysms (brain artery weakness) is around 3.2 percent, with a risk of rupture resulting in a subarachnoid Brain Hemorrhage Market of roughly 10 per 100,000 instances. According to the same source, around the age of 50, the occurrence of cerebral aneurysms rises in females due to lower estrogen levels, which leads to less collagen in the vascular tissue, weakening blood vessel walls.
Over the forecast period, the market is expected to rise due to increased research & development initiatives for the development of innovative therapies for the treatment of brain hemorrhage.
The worldwide brain hemorrhage market is predicted to increase due to key players focusing on research & development activities to develop novel procedures and medications for the treatment of brain hemorrhage throughout the forecast period.
Players to Watch
Baxter, Oxurion NV, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Novartis AG, Bayer AG, Abbott, Bristol-Myers Squibb, Johnson and Johnson, Neurotech Pharmaceuticals, Inc., Siemens Healthcare GmbH, Novo Nordisk A/S, H. Lundbeck A/S, and Ligand Pharmaceuticals Incorporated are some of the major players in the global brain hemorrhage market.
Source Link:https://bit.ly/3s2lC3w
0 Comments